Baillie Gifford & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $343M | Sell |
1,172,808
-805,091
| -41% | -$265M | 0.35% | 59 |
|
|
2025
Q4 | $693M | Sell |
1,977,899
-189,015
| -9% | -$63.9M | 0.58% | 37 |
|
|
2025
Q3 | $700M | Sell |
2,166,914
-70,108
| -3% | -$21.8M | 0.52% | 38 |
|
|
2025
Q2 | $870M | Sell |
2,237,022
-66,016
| -3% | -$26.6M | 0.65% | 30 |
|
|
2025
Q1 | $1B | Sell |
2,303,038
-184,346
| -7% | -$74M | 0.87% | 24 |
|
|
2024
Q4 | $918M | Sell |
2,487,384
-282,184
| -10% | -$118M | 0.71% | 35 |
|
|
2024
Q3 | $1.44B | Sell |
2,769,568
-94,714
| -3% | -$50.6M | 1.08% | 22 |
|
|
2024
Q2 | $1.55B | Sell |
2,864,282
-50,573
| -2% | -$26.7M | 1.21% | 20 |
|
|
2024
Q1 | $1.51B | Sell |
2,914,855
-173,049
| -6% | -$86.1M | 1.18% | 24 |
|
|
2023
Q4 | $1.46B | Buy |
3,087,904
+27,986
| +0.9% | +$12.9M | 1.15% | 20 |
|
|
2023
Q3 | $1.33B | Sell |
3,059,918
-74,331
| -2% | -$33.7M | 1.22% | 20 |
|
|
2023
Q2 | $1.39B | Sell |
3,134,249
-63,764
| -2% | -$29.4M | 1.18% | 20 |
|
|
2023
Q1 | $1.47B | Sell |
3,198,013
-578,029
| -15% | -$275M | 1.33% | 20 |
|
|
2022
Q4 | $1.94B | Sell |
3,776,042
-198,729
| -5% | -$101M | 2.02% | 14 |
|
|
2022
Q3 | $1.81B | Sell |
3,974,771
-91,119
| -2% | -$43.6M | 1.86% | 11 |
|
|
2022
Q2 | $1.96B | Sell |
4,065,890
-106,502
| -3% | -$52.7M | 2.01% | 10 |
|
|
2022
Q1 | $2.05B | Sell |
4,172,392
-409,920
| -9% | -$187M | 1.44% | 15 |
|
|
2021
Q4 | $2.12B | Buy |
4,582,312
+587,649
| +15% | +$247M | 1.17% | 22 |
|
|
2021
Q3 | $1.49B | Sell |
3,994,663
-35,671
| -0.9% | -$13.6M | 0.78% | 33 |
|
|
2021
Q2 | $1.54B | Buy |
4,030,334
+106,248
| +3% | +$40.6M | 0.75% | 33 |
|
|
2021
Q1 | $1.41B | Sell |
3,924,086
-27,583
| -0.7% | -$8.87M | 0.79% | 34 |
|
|
2020
Q4 | $1.27B | Sell |
3,951,669
-91,681
| -2% | -$28.1M | 0.71% | 34 |
|
|
2020
Q3 | $1.09B | Sell |
4,043,350
-52,954
| -1% | -$14.2M | 0.75% | 35 |
|
|
2020
Q2 | $1.08B | Sell |
4,096,304
-774
| -0% | -$206K | 0.82% | 28 |
|
|
2020
Q1 | $930M | Sell |
4,097,078
-40,225
| -1% | -$11M | 1.01% | 24 |
|
|
2019
Q4 | $1.25B | Sell |
4,137,303
-146,621
| -3% | -$40.3M | 1.21% | 19 |
|
|
2019
Q3 | $1.03B | Sell |
4,283,924
-125,648
| -3% | -$34.4M | 1.17% | 20 |
|
|
2019
Q2 | $1.24B | Sell |
4,409,572
-15,516
| -0.4% | -$4.24M | 1.32% | 17 |
|
|
2019
Q1 | $1.27B | Sell |
4,425,088
-36,617
| -0.8% | -$10.6M | 1.39% | 16 |
|
|
2018
Q4 | $1.17B | Buy |
4,461,705
+9,250
| +0.2% | +$2.54M | 1.52% | 14 |
|
|
2018
Q3 | $1.22B | Sell |
4,452,455
-357,618
| -7% | -$92.8M | 1.32% | 19 |
|
|
2018
Q2 | $1.14B | Sell |
4,810,073
-47,941
| -1% | -$11.1M | 1.24% | 17 |
|
|
2018
Q1 | $1.07B | Sell |
4,858,014
-21,108
| -0.4% | -$4.96M | 1.25% | 18 |
|
|
2017
Q4 | $1.1B | Sell |
4,879,122
-53,016
| -1% | -$11.3M | 1.37% | 17 |
|
|
2017
Q3 | $937M | Sell |
4,932,138
-24,989
| -0.5% | -$4.76M | 1.19% | 18 |
|
|
2017
Q2 | $933M | Sell |
4,957,127
-43,538
| -0.9% | -$7.82M | 1.25% | 16 |
|
|
2017
Q1 | $827M | Sell |
5,000,665
-143,324
| -3% | -$22.8M | 1.2% | 17 |
|
|
2016
Q4 | $740M | Sell |
5,143,989
-148,071
| -3% | -$19.8M | 1.22% | 20 |
|
|
2016
Q3 | $663M | Sell |
5,292,060
-61,633
| -1% | -$7.96M | 1.04% | 23 |
|
|
2016
Q2 | $703M | Sell |
5,353,693
-58,474
| -1% | -$8M | 1.25% | 17 |
|
|
2016
Q1 | $752M | Sell |
5,412,167
-11,720
| -0.2% | -$1.57M | 1.32% | 15 |
|
|
2015
Q4 | $756M | Sell |
5,423,887
-1,561
| -0% | -$215K | 1.32% | 17 |
|
|
2015
Q3 | $760M | Buy |
5,425,448
+117,474
| +2% | +$17.7M | 1.49% | 13 |
|
|
2015
Q2 | $871M | Sell |
5,307,974
-535,163
| -9% | -$85.5M | 1.57% | 13 |
|
|
2015
Q1 | $902M | Buy |
5,843,137
+115,795
| +2% | +$16.5M | 1.71% | 12 |
|
|
2014
Q4 | $720M | Buy |
5,727,342
+435,091
| +8% | +$53.8M | 1.44% | 15 |
|
|
2014
Q3 | $633M | Buy |
5,292,251
+80,336
| +2% | +$9.21M | 1.39% | 18 |
|
|
2014
Q2 | $561M | Buy |
5,211,915
+2,184,426
| +72% | +$225M | 1.21% | 24 |
|
|
2014
Q1 | $301M | Buy |
3,027,489
+274,781
| +10% | +$24.9M | 0.71% | 42 |
|
|
2013
Q4 | $254M | Buy |
2,752,708
+363,793
| +15% | +$32.3M | 0.6% | 45 |
|
|
2013
Q3 | $200M | Buy |
2,388,915
+339,286
| +17% | +$29.1M | 0.51% | 50 |
|
|
2013
Q2 | $168M | Buy |
+2,049,629
| New | +$153M | 0.51% | 49 |
|
Other funds holding ELV
VCM
VPM
Baillie Gifford & Co's ELV Position: Q1 2026 in Review
Baillie Gifford & Co reduced its Elevance Health (ELV) stake by 41% in Q1 2026, selling an estimated $265M and leaving 1,172,808 shares worth $343M. The position accounts for 0.35% of the portfolio, ranked #59.
Baillie Gifford & Co first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.12B in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Baillie Gifford & Co held 1,172,808 shares of Elevance Health worth $343M as of Q1 2026.
- Baillie Gifford & Co sold 805,091 Elevance Health shares in Q1 2026, an estimated $265M.
- Elevance Health made up 0.35% of Baillie Gifford & Co's portfolio in Q1 2026, its #59 holding.
- Baillie Gifford & Co first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Baillie Gifford & Co's Elevance Health position peaked at $2.12B in Q4 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Baillie Gifford & Co's 13F filing for Q1 2026, filed 8 May 2026.